Evy Lundgren-Äkerlund

Person

Bjarred, SE

People

Patents Grantslast 30 patents

Information Patent Grant
Quality assurance of chondrocytes
- Patent number 11,725,188
- Issue date Aug 15, 2023
- Xintela AB
- Evy Lundgren Åkerlund
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Prevention and treatment of bone and cartilage damage or disease
- Patent number 11,517,593
- Issue date Dec 6, 2022
- Xintela AB
- Evy Lundgren Åkerlund
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Detection and treatment of malignant tumours in the CNS
- Patent number 10,994,022
- Issue date May 4, 2021
- Xintela AB
- Evy Lundgren-Åkerlund
- G01 - MEASURING TESTING
Information Patent Grant
Quality assurance of chondrocytes
- Patent number 10,781,424
- Issue date Sep 22, 2020
- Xintela AB
- Evy Lundgren Åkerlund
- G01 - MEASURING TESTING
Information Patent Grant
Monoclonal antibody capable of binding integrin alpha 10 beta 1
- Patent number 10,087,253
- Issue date Oct 2, 2018
- Xintela AB
- Evy Lundgren-Åkerlund
- G01 - MEASURING TESTING
Information Patent Grant
Integrin heterodimer and a subunit thereof
- Patent number 10,081,666
- Issue date Sep 25, 2018
- Xintela AB
- Evy Lundgren-Akerlund
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Monoclonal antibody capable of binding integrin alpha 10 beta 1
- Patent number 9,365,649
- Issue date Jun 14, 2016
- Xintela AB
- Evy Lundgren-Åkerlund
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Integrin heterodimer and a subunit thereof
- Patent number 8,895,253
- Issue date Nov 25, 2014
- Xintela AB
- Evy Lundgren-Åkerlund
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoclonal antibody capable of binding integrin alpha 10 beta 1
- Patent number 8,563,255
- Issue date Oct 22, 2013
- Xintela AB
- Evy Lundgren-Åkerlund
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Marker for stem cells and its use
- Patent number 8,105,791
- Issue date Jan 31, 2012
- Xintela AB
- Evy Lundgren-Åkerlund
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody to an integrin heterodimer and/or a subunit thereof
- Patent number 8,048,991
- Issue date Nov 1, 2011
- Xintela AB
- Evy Lundgren-Åkerlund
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoclonal antibody capable of binding integrin alpha 10 beta 1
- Patent number 8,012,696
- Issue date Sep 6, 2011
- Xintela AB
- Evy Lundgren-Åkerlund
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Marker for stem cells and its use
- Patent number 7,749,710
- Issue date Jul 6, 2010
- Xintela AB
- Evy Lundgren-Åkerlund
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Monoclonal antibody capable of binding integrin alpha 10 beta 1
- Patent number 7,452,677
- Issue date Nov 18, 2008
- Cartela R&D AB
- Evy Lundgren-Åkerlund
- G01 - MEASURING TESTING
Information Patent Grant
Integrin heterodimer and a subunit thereof
- Patent number 7,029,858
- Issue date Apr 18, 2006
- Cartela AB
- Evy Lundgren-Åkerlund
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Marker for Neural Stem Cells
- Publication number 20250020646
- Publication date Jan 16, 2025
- Xintela AB
- Evy LUNDGREN ÅKERLUND
- G01 - MEASURING TESTING
Information Patent Application
Mesenchymal Stem Cells for Use in the Treatment of Skin Defects
- Publication number 20240245726
- Publication date Jul 25, 2024
- Xintela AB
- Evy Lundgren Åkerlund
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Stem Cells for Treatment of Respiratory Disorders
- Publication number 20230346843
- Publication date Nov 2, 2023
- Xintela AB
- Evy Lundgren Åkerlund
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Quality Assurance of Chondrocytes
- Publication number 20230348857
- Publication date Nov 2, 2023
- Xintela AB
- Evy Lundgren Åkerlund
- G01 - MEASURING TESTING
Information Patent Application
Prevention and treatment of bone and cartilage damage or disease
- Publication number 20230128397
- Publication date Apr 27, 2023
- Xintela AB
- Evy Lundgren Åkerlund
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTEGRIN ALPHA10 AND AGGRESSIVE CANCER FORMS
- Publication number 20220177591
- Publication date Jun 9, 2022
- Targinta AB
- Evy Lundgren Åkerlund
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Detection and Treatment of Malignant Tumours in the CNS
- Publication number 20210316005
- Publication date Oct 14, 2021
- Xintela AB
- Evy Lundgren-Åkerlund
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
QUALITY ASSURANCE OF CHONDROCYTES
- Publication number 20200377858
- Publication date Dec 3, 2020
- Xintela AB
- Evy Lundgren Åkerlund
- G01 - MEASURING TESTING
Information Patent Application
Prevention and treatment of bone and cartilage damage or disease
- Publication number 20200038449
- Publication date Feb 6, 2020
- Xintela AB
- Evy Lundgren Åkerlund
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Marker for Neural Stem Cells
- Publication number 20190369093
- Publication date Dec 5, 2019
- Xintela AB
- Evy LUNDGREN ÅKERLUND
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Quality Assurance of Chondrocytes
- Publication number 20190300855
- Publication date Oct 3, 2019
- Xintela AB
- Evy Lundgren Åkerlund
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Detection and treatment of malignant tumours in the CNS
- Publication number 20180236094
- Publication date Aug 23, 2018
- Xintela AB
- Evy Lundgren-Åkerlund
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTEGRIN HETERODIMER AND A SUBUNIT THEREOF
- Publication number 20180079795
- Publication date Mar 22, 2018
- Xintela AB
- Evy Lundgren-Akerlund
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INTEGRIN HETERODIMER AND A SUBUNIT THEREOF
- Publication number 20170121386
- Publication date May 4, 2017
- Xintela AB
- Evy Lundgren-Akerlund
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MONOCLONAL ANTIBODY CAPABLE OF BINDING INTEGRIN ALPHA 10 BETA 1
- Publication number 20160319023
- Publication date Nov 3, 2016
- Xintela AB
- Evy Lundgren-Akerlund
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MONOCLONAL ANTIBODY CAPABLE OF BINDING INTEGRIN ALPHA 10 BETA 1
- Publication number 20140099716
- Publication date Apr 10, 2014
- Xintela AB
- Evy Lundgren-Äkerlund
- G01 - MEASURING TESTING
Information Patent Application
INTEGRIN HETERODIMER AND A SUBUNIT THEREOF
- Publication number 20130137118
- Publication date May 30, 2013
- Xintela AB
- Evy Lundgren-Akerlund
- G01 - MEASURING TESTING
Information Patent Application
Integrin Heterodimer And A Subunit Thereof
- Publication number 20120136141
- Publication date May 31, 2012
- XINTELA AB
- Evy Lundgren-Akerlund
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Monoclonal Antibody Capable of Binding Integrin Alpha 10 Beta 1
- Publication number 20120034625
- Publication date Feb 9, 2012
- XINTELA AB
- Evy Lundgren-Äkerlund
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Binding agents to the Integrin Alpha-11 subunit, and uses thereof
- Publication number 20110256061
- Publication date Oct 20, 2011
- Evy Lundgren-Akerlund
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MARKER FOR STEM CELLS AND ITS USE
- Publication number 20110033923
- Publication date Feb 10, 2011
- XINTELA AB
- Evy Lundgren-Akerlund
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF INTEGRIN ALPHA 10 BINDING ANTIBODY TO MODULATE EXTRACELLULAR...
- Publication number 20100055114
- Publication date Mar 4, 2010
- Evy Lundgren-Akerlund
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Expansion and Differentiation of Mesenchymal Stem Cells
- Publication number 20090232777
- Publication date Sep 17, 2009
- Evy Lundgren-Akerlund
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Monoclonal antibody capable of binding integrin alpha 10 beta 1
- Publication number 20090185978
- Publication date Jul 23, 2009
- Cartela R&D AB
- Evy Lundgren-Akerlund
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Methods and uses of the integrin alpha 10 chain, for preventing pro...
- Publication number 20080159956
- Publication date Jul 3, 2008
- Hansa Medical AB
- Evy Lundgren-Akerlund
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibody to an integrin heterodimer and/or a subunit thereof
- Publication number 20060178503
- Publication date Aug 10, 2006
- Cartela AB
- Evy Lundgren-Akerlund
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Monoclonal antibody capable of binding integrin alpha 10 beta 1
- Publication number 20060127398
- Publication date Jun 15, 2006
- Evy Lundgren-Akerlund
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Knockout mice and their use
- Publication number 20060123495
- Publication date Jun 8, 2006
- Donald Gullberg
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
Methods and uses of the integrin alpha 10 chain, for preventing pro...
- Publication number 20050255182
- Publication date Nov 17, 2005
- CARTELA AB
- Evy Lundgren-Akerlund
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Marker for stem cells and its use
- Publication number 20050221327
- Publication date Oct 6, 2005
- CARTELA AB
- Evy Lundgren-Akerlund
- C07 - ORGANIC CHEMISTRY

Evy Lundgren-Äkerlund

Person

Patents Grantslast 30 patents

Quality assurance of chondrocytes

Prevention and treatment of bone and cartilage damage or disease

Detection and treatment of malignant tumours in the CNS

Quality assurance of chondrocytes

Monoclonal antibody capable of binding integrin alpha 10 beta 1

Integrin heterodimer and a subunit thereof

Monoclonal antibody capable of binding integrin alpha 10 beta 1

Integrin heterodimer and a subunit thereof

Monoclonal antibody capable of binding integrin alpha 10 beta 1

Marker for stem cells and its use

Antibody to an integrin heterodimer and/or a subunit thereof

Monoclonal antibody capable of binding integrin alpha 10 beta 1

Marker for stem cells and its use

Monoclonal antibody capable of binding integrin alpha 10 beta 1

Integrin heterodimer and a subunit thereof

Patents Applicationslast 30 patents

Marker for Neural Stem Cells

Mesenchymal Stem Cells for Use in the Treatment of Skin Defects

Stem Cells for Treatment of Respiratory Disorders

Quality Assurance of Chondrocytes

Prevention and treatment of bone and cartilage damage or disease

INTEGRIN ALPHA10 AND AGGRESSIVE CANCER FORMS

Detection and Treatment of Malignant Tumours in the CNS

QUALITY ASSURANCE OF CHONDROCYTES

Prevention and treatment of bone and cartilage damage or disease

Marker for Neural Stem Cells

Quality Assurance of Chondrocytes

Detection and treatment of malignant tumours in the CNS

INTEGRIN HETERODIMER AND A SUBUNIT THEREOF

INTEGRIN HETERODIMER AND A SUBUNIT THEREOF

MONOCLONAL ANTIBODY CAPABLE OF BINDING INTEGRIN ALPHA 10 BETA 1

MONOCLONAL ANTIBODY CAPABLE OF BINDING INTEGRIN ALPHA 10 BETA 1

INTEGRIN HETERODIMER AND A SUBUNIT THEREOF

Integrin Heterodimer And A Subunit Thereof

Monoclonal Antibody Capable of Binding Integrin Alpha 10 Beta 1

Binding agents to the Integrin Alpha-11 subunit, and uses thereof

MARKER FOR STEM CELLS AND ITS USE

USE OF INTEGRIN ALPHA 10 BINDING ANTIBODY TO MODULATE EXTRACELLULAR...

Expansion and Differentiation of Mesenchymal Stem Cells

Monoclonal antibody capable of binding integrin alpha 10 beta 1

Methods and uses of the integrin alpha 10 chain, for preventing pro...

Antibody to an integrin heterodimer and/or a subunit thereof

Monoclonal antibody capable of binding integrin alpha 10 beta 1

Knockout mice and their use

Methods and uses of the integrin alpha 10 chain, for preventing pro...

Marker for stem cells and its use